Broadhead J, Rouan S K, Rhodes C T
Department of Pharmaceutics, University of Rhode Island, Kingston 02881, USA.
Pharm Acta Helv. 1995 Jul;70(2):125-31. doi: 10.1016/0031-6865(95)00005-t.
We have previously developed a spray dried formulation of a model protein (beta-galactosidase) of a size suitable for evaluation in dry powder inhaler devices. In this study, we wished to evaluate the roles of various methods available for the laboratory testing of dry powders for inhalation (cascade impactor, twin impinger, aerodynamic time of flight and image analysis). Secondly we wished to compare different inhaler devices using formulations with and without a carrier. Both the cascade impactor and twin impinger were appropriate methods for the testing of dry powder inhalers, and gave comparable estimates of respirable fraction. Image analysis and aerodynamic time of flight were suitable methods for determining the particle size of the dry powders, although the former was considerably more time consuming than the latter. The four inhalers evaluated differed greatly in terms of in vitro deposition properties. The presence of a carrier significantly improved respirable fraction with the poorer inhalers, but was less critical to the performance of the more efficient devices.
我们之前研发了一种喷雾干燥制剂,其为一种大小适合在干粉吸入装置中进行评估的模型蛋白(β-半乳糖苷酶)。在本研究中,我们希望评估可用于吸入用干粉实验室检测的各种方法(多级撞击式采样器、双级冲击式采样器、飞行时间气动分析法和图像分析)的作用。其次,我们希望使用含载体和不含载体的制剂比较不同的吸入装置。多级撞击式采样器和双级冲击式采样器都是检测干粉吸入器的合适方法,并且对可吸入部分给出了可比的估计值。图像分析和飞行时间气动分析法是测定干粉粒径的合适方法,尽管前者比后者耗时得多。所评估的四种吸入器在体外沉积特性方面差异很大。载体的存在显著提高了较差吸入器的可吸入部分,但对更高效装置的性能影响较小。